13F Pro13F Pro

SEC Form 4 reporting owner

Young Wendy B.

Young Wendy B. has filed 4 Form 4 transactions reported between June 10, 2026 and October 22, 2026, as a reporting owner of Rapport Therapeutics, Inc. and Director of Azora Therapeutics, Inc. (DE).

Name as filed: Young Wendy B.

Follow Young Wendy B. and get an alert on every new Form 4

Young Wendy B. holds 13,289 shares of RAPP, worth $313K, 0.02% of the company.

As of their Oct 22, 2026 Form 4 (filed Oct 22, 2026) · the filing on SEC EDGAR · valued at the Nov 19, 2026 close of $23.59 · 59.3M shares outstanding on Nov 2, 2026

Young Wendy B. holds at least 36,378 shares of AZR, worth $141K, 0.25% of the company.

As of their Jun 12, 2026 Form 4 · the filing on SEC EDGAR · valued at the Nov 19, 2026 close of $3.87 · 14.3M shares outstanding on Nov 9, 2026

Counted from the latest direct line and the latest indirect line that traded. Shares held through other trusts or entities that did not trade are not included yet, so the true holding can be larger.

Open-market buys, 24 mo
$200K
2 lines
Open-market sales, 24 mo
None
reported
Companies
2
with Form 4 filings
Latest transaction
Oct 22, 2026
transaction date

Roles and reported holdings

  • RAPPRapport Therapeutics, Inc.
    Jun 10, 2026 – Oct 22, 2026

    Reporting owner

    Held directly13,289 sh

    As of Oct 22, 2026 · Form 4

    24 months: $100K bought

  • AZRAzora Therapeutics, Inc. (DE)
    Jun 12, 2026 – Sep 17, 2026

    Director

    Held directly36,378 sh

    As of Jun 12, 2026 · Form 4

    24 months: $100K bought

How their buys did since

2 open-market purchases against today’s price: +15.1% on average, +15.1% weighted by dollars spent.

DatePaidReturn
Oct 22, 2026RAPP$26.39-10.6%now $23.59
Jun 12, 2026AZR$2.75+40.8%now $3.87

Each purchase at the price on its Form 4, against the latest trade or close, adjusted for stock splits. Past returns say nothing about future ones.

Transaction history

All 4 reported transactions, newest first. Every row links to the Form 4 on SEC EDGAR.

DateCompanyTypeSharesValueFiling
Oct 22, 2026RAPPOpen-market purchaseCode P · direct3,789$100K@ $26.39Form 4
Sep 17, 2026AZRDirectorGrant or awardCode A · direct25,666—Form 4
Jun 12, 2026AZRDirectorOpen-market purchaseCode P · direct36,378$100K@ $2.75Form 4
Jun 10, 2026RAPPGrant or awardCode A · direct15,200—Form 4

How this page is built

Every row comes from a Form 4 filed with the SEC, which officers, directors and holders of more than 10% of a company’s stock must file within two business days of a trade. Transactions are grouped by the reporting owner’s name as filed (spacing, capitals and punctuation ignored); two different people filing under an identical name would appear together, and one person filing under two spellings appears on two pages.

Open-market totals count code P purchases and code S sales over the last 24 months. The same trade reported on more than one filing is counted once; when another owner (for example a fund and its general partner) reports the identical trade, they are listed beside it. Holdings are the shares each ownership line is left at by the person’s latest Form 4, 4/A or 5: held directly, and through each trust or entity named on the filing. A second class of common stock that converts into the listed one counts as shares; options and restricted stock units are listed but not counted. Value uses the latest trade or close, and the share of the company uses the latest shares-outstanding count the company reported. Where a filing has not yet been read line by line, the figure comes from the latest direct and indirect lines that traded and is shown as “at least”.

This page describes what was filed with the SEC; it is not investment advice or a recommendation to buy or sell any security.